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ABSTRAK
Hampir 80% pasien dispepsia yang berobat ke rumah sakit merupakan dispepsia fungsional. Dispepsia 
fungsional walaupun tidak meningkatkan mortalitas, namun dapat menjadi beban bagi komunitas dan negara, 
karena menimbulkan gangguan terhadap fisik, mental dan sosial pasien, sehingga berpengaruh terhadap 
kualitas hidup pasien. Kualitas hidup terkait kesehatan merupakan konstruksi multidimensi yang terdiri dari 
setidaknya tiga domain yaitu fungsi fisik, psikologis dan sosial yang ketiganya dipengaruhi oleh penyakit dan 
pengobatan yang diberikan. Penilaian kualitas hidup terkait kesehatan merupakan hal yang penting pada 
pasien dispepsia fungsional untuk dapat mengidentifikasi dampak dari penyakit dan pengobatan yang diberikan 
kepada pasien. Instrumen generik dan spesifik penyakit dapat digunakan untuk menilai kualitas hidup terkait 
kesehatan pada pasien dispepsia fungsional. Masing-masing instrumen memiliki kelebihan dan keterbatasan. 
Pemilihan instrumen untk menilai kualitas hidup terkait kesehatan ditentukan berdasarkan populasi penelitian, 
pertanyaan penelitian, entitas penyakit, dan preferensi dari peneliti. Tujuan dari penulisan artikel ini adalah 
untuk menjelaskan mengenai konsep kualitas hidup terkait kesehatan dan penilaian kualitas hidup terkait 
kesehatan pada pasien dispepsia fungsional.
Kata kunci: kualitas hidup terkait kesehatan, dispepsia fungsional.
ABSTRACT
In up to 80% of dyspepsia patients who consult a physician in the hospital, dyspepsia is considered to be 
functional dyspepsia. Although not associated with increased mortality, functional dyspepsia is a burden at both 
the community and national levels because it can cause physical, mental, and social distress that can affect a 
patient’s quality of life. Health-related quality of life (HRQOL) is a multidimensional construct comprising at 
least three broad domains—physical, psychological, and social functioning—which can all be affected by a 
disease and its treatment. It is important to assess HRQOL in patients with functional dyspepsia to identify the 
effects of the disease and its treatment on patients. Both disease-specific and generic instruments can be used to 
assess HRQOL in patients with functional dyspepsia. Each instrument has its own advantages and limitations. 
The selection of instrument to assess HRQOL is determined by the study population, research questions, disease 
entities, and researcher preferences. The purpose of this article is to explain the concept of HRQOL and the use 
of HRQOL assessment in patients with functional dyspepsia.
Keywords: health-related quality of life, functional dyspepsia.
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INTRODUCTION
Symptoms of dyspepsia are common in the 
community and clinical practice.1 In up to 80% of 
dyspepsia patients who consult a physician in the 
hospital, the condition is classified as functional 
dyspepsia.1,2 Functional dyspepsia is defined as 
the presence of symptoms thought to originate in 
the gastroduodenal region in the absence of any 
organic, systemic, or metabolic disease that is 
likely to explain the symptoms. The Rome criteria 
subdivide functional dyspepsia into postprandial 
distress syndrome and epigastric pain syndrome).3 
The pathophysiology of functional dyspepsia is 
complex and is not fully understood, although 
it is known that abnormal gut motility, visceral 
hypersensitivity, genetic influence, infection, and 
psychosocial factors play a role.4
Functional dyspepsia is a burden at both 
the community and national levels. It carries 
significant direct and indirect costs and decreases 
work productivity.5,6 Although functional 
dyspepsia is not associated with increased 
mortality,7 it can lead to physical, mental, and 
social distress, which can affect the quality of 
life.8–14
Health-related quality of life (HRQOL) is 
increasingly being assessed as a patient-reported 
outcome in clinical research.15,16 It is important 
to assess HRQOL in patients with functional 
dyspepsia to identify the effects of the disease 
and its treatment in patients.17,18 Both disease-
specific and generic instruments can be used 
to assess HRQOL in patients with functional 
dyspepsia.19 However, as a new concept, HRQOL 
is not well understood by many clinicians in 
Indonesia, and its use in research and clinical 
practice is lacking. The purpose of this article is 
to explain the concept of HRQOL and the use of 
HRQOL assessment in patients with functional 
dyspepsia.
D E F I N I T I O N O F H E A LT H-R E L AT E D 
QUALITY OF LIFE
The World Health Organization defines 
quality of life as an “individual’s perception of 
their position in life in the context of the culture 
and value systems in which they live and in 
relation to their goals, expectations, standards 
and concerns”.20 HRQOL is a multidimensional 
construct comprising at least three broad 
domain physical, psychological, and social 
functioning which can all be affected by disease 
and treatment.21 The term HRQOL is used to 
differentiate this measure from other more 
general aspects of life that are not considered to 
be health related such as income, freedom, and 
quality of the environment.22
W H Y M E A S U R E H E A LT H-R E L AT E D 
QUALITY OF LIFE?
Physicians often rely on objective findings 
when managing patients.17 However, patients 
may be less interested in the value of traditional 
biomarkers than physicians.23 Moreover, 
traditional biomarkers often fail to correlate with 
functional capacity and well-being.22 Assessment 
of HRQOL may counter this problem, and help 
physicians to understand that patients often 
value outcomes in a different way than their 
physician.23
HRQOL assessment can guide physicians 
when making a clinical decision in situations in 
which there may be multiple effective strategies 
from which to choose. HRQOL can offer an 
added value when choosing a treatment when 
there may be only a small difference in survival 
between treatments. Physicians can also use 
HRQOL to help them decide on a treatment 
strategy for patients with asymptomatic or mildly 
symptomatic disease.18
Measuring HRQOL is important for 
understanding the effects of chronic disease, 
especially for those diseases with major effects 
on morbidity but not mortality.22,23 Determining 
disease burden by using traditional measures 
such as the prevalence of a disease, direct and 
indirect costs, and effects on productivity is 
insufficient for understanding the true burden 
of any disease.23 Identifying the adverse effects 
of a disease on HRQOL is important for society 
and health providers to appreciate fully the true 
burden. HRQOL data can also help national 
health policy makers when developing a 
healthcare budget.23,24
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HOW TO CHOOSE A HEALTH-RELATED 
QUALITY OF LIFE INSTRUMENT
The best and most relevant way to assess 
HRQOL is to ask patients by using a validated 
questionnaire.17 HRQOL instruments include a 
range of questions that correspond to the number 
of domains assessed. A domain is an area of 
behavior or experience and questions may relate 
to mobility, self-care, depression, anxiety, and 
well-being.22 The selection of the specific HRQOL 
instrument to be used is determined by the study 
population, research questions, disease entities, 
and researcher preferences.18 Each instrument 
has its own advantages and limitations. Most 
current research uses a combination of generic 
and specific instruments. This combination can 
overcome the limitations of the use of only 
one type of instrument and help to obtain good 
sensitivity and generalizability.18,25 Nevertheless, 
the combined use HRQOL instruments may 
also increase the time required for the patient 
to complete the questionnaires, and modified 
questionnaires have been developed.18
GENERIC INSTRUMENTS
The generic questionnaire allows physicians 
and researchers to evaluate comprehensively 
the effects of different illnesses and symptoms 
on quality of life. Generic instruments can be 
used to compare HRQOL in patients with that in 
other groups with or without illness.17 However, 
a major limitation of generic instruments is that 
they may not include unique and important 
indicators for some special groups and may 
therefore be less sensitive to changes in specific 
symptoms.18,25 Generic instruments are more 
reliable for identifying the general effects on 
wide range of daily activities, mental health and 
functioning.17,26
The Short Form 36 Health Survey (SF-36) is 
the most commonly used generic questionnaire 
in gastroenterology research.18,19 The SF-36 was 
originally developed to assess the health status 
of participants in the Medical Outcomes Study 
This instrument is designed for use in clinical 
practice and research, health policy evaluation, 
and surveys in the general population.19,27 The 
SF-36 is commonly used to define and measure 
differences in HRQOL between patients with 
gastrointestinal disease and control populations.27 
The SF-36 includes one scale for each of eight 
measured health domains: physical functioning, 
role–physical, bodily pain, general health, 
vitality, social functioning, role–emotional, and 
mental health. The scores for these eight domains 
are aggregated into a physical component 
summary (PCS) and mental component summary 
(MCS). The PCS correlates with the scale of 
physical functioning, role–physical, and bodily 
pain, and the MCS correlates with mental health, 
role–emotional, and social functioning. Three 
scales of vitality, general health, and social 
functioning correlate with both component 
summaries.28 All health domains are scored 
using norm-based scores ranging 0 to 100, with 
higher scores indicating better health. The SF-36 
questionnaire can be self-administered by the 
patient, in a direct interview, or by telephone. 
The time required to complete the questionnaire 
is 5–10 minutes for most people and about 15 
minutes in older people.28,29
The SF-36 instrument has been tested for 
reliability and validity. The median internal 
consistency alpha coefficient obtained from 
several studies is >0.8 for all scales except for 
social functioning, which has an alpha coefficient 
of 0.76. The test–retest correlation over 2 weeks 
is >0.8 for the physical functioning, vitality, and 
general health scales. The lowest coefficient 
of 0.6 is for the social functioning scale.29 The 
content validity of the SF-36 has been compared 
with other widely used generic health surveys. 
Systematic comparisons show that the SF-36 
includes eight of the most frequently assessed 
health concepts. Some concepts not covered 
in the SF-36 including cognitive functioning, 
sleep, health distress, social support, family 
and marital functioning, sexual functioning, 
and physical and psychophysiologic symptoms.
Evaluation of 32 general concepts and 19 specific 
symptoms with eight scales and two summaries 
of the SF-36 show that the SF-36 scales correlate 
(r>0.4) with most general health concepts and 
with the frequency and severity of specific 
symptoms and problems.28 The results of the 
analysis of the seven dimensions of the SF-36 
evaluating functioning and well-being were 
strongly associated with patient reports of overall 
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general health. Kruskal-Wallis tests indicated 
clear linear trends for decreasing SF-36 scores 
(i.e., reporting more health related problems) on 
all seven dimensions with worsening self-rated 
general health.30 The SF-36 has been translated 
and validated for use in Indonesia.31
DISEASE-SPECIFIC INSTRUMENTS
A disease-specific instrument is designed 
to detect changes in HRQOL that may not be 
detected using a generic instrument but may be 
important manifestations of disease. Specific 
instruments tend to be more sensitive than 
generic instruments.26 However, an overly 
sensitive disease-specific instrument has the 
disadvantage of possibly detecting clinically 
unimportant changes in the placebo group.25 
Another limitation is that, because of its narrow 
focus, a specific instrument may be unable to 
detect unexpected major changes in the HRQOL 
and cannot be used widely for different diseases.26 
Instruments may be specific to a disease (such 
as heart failure or asthma), a patient population 
(such as the frail elderly) to certain functions 
(such as sleep or sexual function), or specific 
problems (such as pain).22 The Irritable Bowel 
Syndrome Quality of Life instrument and Nepean 
Dyspepsia Index (NDI) are examples of specific 
questionnaires commonly used in functional 
gastrointestinal disorders in Asia.19
The NDI was developed by a team of 
researchers in Sydney,  Austral ia.  The 
questionnaire originally comprised 42 questions 
that assessed quality of life in 17 major aspects 
and a list of symptom frequency, intensity, and 
disturbance of 15 upper gastrointestinal symptoms 
within the past 2 weeks. The assessment of this 
questionnaire uses a five-level Likert scale. The 
questionnaire has been translated from Australian 
English into French, Dutch, Italian, German, 
Spanish, and American English.32 The NDI was 
simplified from 42 questions to 25 questions 
for five subscales (domains): effects on general 
tension/sleep (nine items), interference with daily 
activities (six items), effects on eating/drinking 
(three items), knowledge/control of dyspepsia 
(four items), and the effects of dyspepsia on 
work/study (three items). Validity testing noted 
good face validity and internal consistency 
results; Cronbach’s a for all subscales was >0.85. 
Good reliability of the questionnaire has also 
been reported, with an intraclass correlation of 
all subscales of >0.84.33
The NDI questionnaire was further 
simplified into 10 questions with each subscale 
comprising two questions. The NDI evaluates 
the symptoms and HRQOL in patients with 
functional dyspepsia. The quality of life subscale 
associated with symptoms can be used to assess 
directly the severity of disease symptoms. The 
questionnaire is responsive and has sufficient 
internal consistency (>0.7) for all scales as well 
as a strong and meaningful correlation with the 
complete questionnaire.34 A short-form NDI has 
been translated and its validity tested for use in 
Indonesia.35
CONCLUSION
It is important to assess HRQOL in patients 
with functional dyspepsia to identify the effects 
of the disease and its treatment in patients. Both 
disease-specific and generic instruments can be 
used to assess HRQOL in patients with functional 
dyspepsia. Understanding the advantages and 
limitations of both generic and disease-specific 
instruments is critical when choosing to assess 
HRQOL in patients with functional dyspepsia.
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